|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.013 AUD | 0.00% |
|
0.00% | -27.78% |
| Mar. 22 | Hexima Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
| Mar. 19 | Hexima Changes Address | MT |
Hexima Limited announced that Geoffrey Kempler has been appointed as the new Chairman and Managing Director of the Company to lead the future direction of the Company. Mr. Kempler is Chairman of AusBiotech and Chairman and Founder of ASX-listed Alterity Therapeutics Limited. He is a qualified psychologist with extensive experience in investment and business development.
Appointment Date is 05 September 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.78% | 1.42M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
HEXIMA LIMITED 
